- 1 The first comparison between European health services for the treatment of pancreatic cancer suggests that most countries do not give proper attention to the disease.
The first comparison between European health services for the treatment of pancreatic cancer suggests that most countries do not give proper attention to the disease.
Although pancreatic cancer accounts for almost the same number of deaths by breast cancer, health care systems do not take him seriously.
4 on 5 countries, among which and Greece, the data on the results of treatment are not monitored and there is no approved best practice. The above demonstrates the European Leader Board Cancer of Pancreas (European Pancreatic Cancer Index- EPCI), which was published by the research organization Health Consumer Powerhouse (HCP) with headquarters in Sweden.
Will have to focus on the key on health care for pancreatic cancer: Medical Training with a view to early detection of cancer and monitoring of key data in the context of treatment says Dr. Arne Bjornberg, chief training leaderboards of HCP.
Care hinders the effective treatment of cancer. Failure to monitor the performance leads to disorientation. In Greece, prevention and access to pharmaceuticals seem to continue to operate, but compassionate and palliative treatment obviously presents a bleak picture. ”
Pancreatic cancer has justified its reputation “silent killer”.
In general, detected too late, which makes the treatment almost impossible. Doctors need better training for the early detection of disease. Pancreatic cancer is the fourth most important cause of cancer death in the European Union and is responsible for the deaths of more than 100,000 Europeans every year. Unlike other cancers, the number for this disease continues to grow!
Brought about by the disease, most countries do not have a best practice for treatment. Four of the five countries can not provide evidence of the results of treatment. The EPCI table shows that the chances of survival are two times higher in the European countries with the best performance in relation to the countries with the lowest performance.
Ann-Marie Yazbeck, manager of EPCI project. “The Netherlands, Denmark, France and Ireland have satisfactory results.
Doctors seem to be more informed about the disease and the results of treatment are monitored and documented comparatively satisfactorily. The encouraging is that we can determine the strategic steps that will allow us to make progress. The monitoring and documentation of treatment are components which Greece should improve significantly”
thpillars on which
Can to build a potential pan-European best practice for pancreatic cancer:
– Primary care physicians should be trained to be vigilant for pancreatic cancer and can recognize a combination of vague symptoms.
– Early detection is absolutely necessary for effective treatment.
– Fast access to specialist diagnosis and surgery.
– Systematic, affordable monitoring and documentation of the results of the treatment.
– Informing patients about treatment options, with lists of certified surgeons for pancreatic cancer and border care opportunities.
The table – which is the first comparison of health services for pancreatic cancer in Europe – covering the following areas, using 30 indicators: Right, information and patient access to health care, prevention, treatments results, diagnosis, drugs and palliative and palliative treatment.
As evidenced by the national benchmarks of EPCI, there is a wide distribution of the results in the table, with an unusual combination of countries with high and middle income to upper half of the ranking positions.
The Netherlands comes first (as in many other ranking lists of HCP) with 879 points out of a possible total of 1000 finally, the United Kingdom decent fifth position (800), although some of the lower survival in Europe! The Greece (582) is in the 22nd position.